Risk of long-lasting serious adverse reactions: a reminder of restrictions on the use of antibacterial agents of the fluoroquinolone class (LEVOSTAD®))"

31.10.2023 1630 views

Ризик виникнення тривалих серйозних побічних реакцій: нагадування про обмеження застосування антибактеріальних засобів, що належать до класу фторхінолонів (ЛЕВОСТАД®))»PDF · 644 КБ

Завантажити

Risk of long-lasting serious adverse reactions: a reminder of restrictions on the use of antibacterial agents of the fluoroquinolone class (LEVOSTAD®))"

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Risk of long-lasting serious adverse reactions: a reminder of restrictions on the use of antibacterial agents of the fluoroquinolone class (LEVOSTAD®))"

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration